Search results
FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants
Fortune· 4 days ago“The mutations will keep happening.” The Omicron variant of SARS-CoV-2, the coronavirus that causes COVID-19, has been circling the globe ...
New sexually transmitted fungal infection - ringworm - found in NYC marks 1st case in US
USA Today· 3 days agoMedical experts are warning doctors and the public of a highly contagious rare fungal strain after a...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks· 5 days agoIn this meeting, members of the VRBPAC will discuss whether to update the currently authorized COVID-19 vaccines to target the JN.1 variant< ...
New COVID variant FLiRT may be more transmissible but unlikely to make us more sick
NPR· 5 days agoAILSA CHANG, HOST: As much as we would all love to ignore COVID, a new set of variants that scientists call FLiRT - that's with a lowercase I - is here to remind us that COVID ...
A lone star tick bite can cause a meat allergy: Here's what to watch out for this summer
USA Today· 1 day agoAlpha-gal syndrome is a serious and life-threatening allergic reaction that appears in mammals after...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Midland Reporter-Telegram· 3 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Associated Press via AOL· 3 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA panel recommends new COVID-19 vaccine formula for fall
United Press International via Yahoo News· 3 days agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 6 days agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...